MedPath

Discovery of Arthritis in Psoriasis Patients for Early Rheumatological referral (DAPPER

Completed
Conditions
psoriasis
psoriatic arthritis
10023213
10014982
Registration Number
NL-OMON48399
Lead Sponsor
Radboud Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
300
Inclusion Criteria

* Diagnosis of cutaneous psoriasis
* Age 18 years or above
* Willing and able to comply with visits and study-related procedures
* Provide signed informed consent (IC)

Exclusion Criteria

* Age below 18 years
* Unable to give IC
* Unable or unwilling to comply with visits and study-related procedures
* Participation in other trials involving PsO

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The prevalence of (newly discovered) PsA in known PsO patients in the setting<br /><br>of a university dermatology outpatient clinic. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary endpoints will be the difference between both populations with regard<br /><br>to several markers. These markers will be used to develop a new screening tool.<br /><br>QoL parameters, and the change after 1 year, will also be evaluated.</p><br>
© Copyright 2025. All Rights Reserved by MedPath